Today's episode explores considerations worth taking into account when deciding to implement a medical surveillance program as recommended by the USP Chapter <800> Standard.
SPEAKERS
Kimberly Mehta serves as the Director of Medication Safety and Regulatory for the Allegheny Health Network. Kim received her Doctor of Pharmacy from the University Of Pittsburgh School Of Pharmacy, Master of Public Health from Pitt, School of Public Health and her Master of Health Administration from Walden University. She completed a combined PGY1/PGY2 Health System Pharmacy Administration Residency at Allegheny Health Network. Kim is an active member in local, state, and national organizations. She is the current president of the Western chapter of PSHP and chairs the Medication Safety Committee of PSHP. Kim has previously collaborated with the Virginia Department of Health, Northwest Virginia Regional Drug and Gang Task Force, and other local organizations to increase the role and engagement of pharmacists and support public health and safety initiatives focused in both Emergency Preparedness and combating the opioid epidemic. At a national level, Kim is an active member of American Society of Health System Pharmacists (ASHP), having served on several section advisory groups. Kim is the 2020-21 Vice Chair of the Section Advisory Group on Medication Safety. Through ASHP she has been involved with several national initiatives and groups including the USP 800 task force resulting in FAQ documents and creation of several national webinars on USP topics. Kim’s professional interests include patient safety and quality, sterile and non-sterile compounding, technology solutions, and healthcare reform.
Michael Ganio Pharm.D., M.S., BCPS, FASHP, is Senior Director, Pharmacy Practice and Quality at ASHP. Dr. Ganio joined the staff at ASHP as Director of Pharmacy Practice and Quality in January of 2018. As a member of the Center on Medication Safety and Quality team, his responsibilities span the practice of pharmacy and include drug shortages, pharmaceutical quality, sterile and non-sterile drug compounding practices, hazardous drug safety, and other practice-related topics.
Dr. Ganio earned his Pharm.D. from the Rutgers University Ernest Mario School of Pharmacy and his Master’s degree in Health-System Pharmacy Administration from The Ohio State University College of Pharmacy. He completed a PGY1 Pharmacy Practice residency at The Ohio State University Wexner Medical Center. Dr. Ganio is a Board Certified Pharmacotherapy Specialist (BCPS) and is a Certified Professional in Healthcare Information and Management Systems (CPHIMS).
Dr. Ganio has nearly 20 years of hospital and health-system experience. His previous job roles have included clinical pharmacy practice, pharmacy informatics and technology, and outpatient oncology pharmacy operations. He has extensive knowledge of drug shortage management, pharmaceutical quality, pharmacy informatics and automation, medication billing and reimbursement, sterile compounding, and outpatient infusion and ambulatory-care practice models.